09 October 2013 Wednesday

16:00-16:30

Opening Speech

Dr. Süleyman Dinçer

The Opening Session of the Congress
Moderators: Dr. Giuseppe Saglio, Dr. Birol Guvenc, Dr. Irina Poddubnaya

16:30-17:00

Treatment of Acute Myeloid Leukemia: Are We Making Progress?

Dr. Alan Burnett

17:00-17:30

New Strategies With Minimal Residual Disease and Targeted Therapy in Adult Acute Lymphoblastic Leukemia

Dr. Dieter Hoelzer

17:30-18:00

HL Therapy in 2013: Possible Approaches

Dr. Alessandro Levis

18:00-18:30

Iron Overload in MDS

Dr. Eliezer Rachmilewitz

18:30-19:00

Cancer Stem Cells: An Update

Dr. Albert Donnenberg

19:00

Opening Cocktail

10 October 2013 Thursday

Complications and Hematologic Infections Sessions
Moderators: Dr. Sema Anak, Dr. Ali Unal, Dr. Gulyuz Ozturk

 09:00-09:30

New Antibiotic Strategy in Neutropenia

Dr. Ömrüm Uzun

 09:30-10:00

The Patient at the Centre of IFI Management: Putting Theory Into Practice

Dr. Samir Agrawal

10:00-10:30

Profilactic Anti Fungal Treatment in Hematologic Malignancies

Dr. Esin Şenol

10:30-10:45

Coffee Break

MPN
Moderators: Dr. Aysen Timuragaoglu, Dr. Cengiz Beyan

10.45-11:15

Molecular Genetics of MPNs

Dr. Daniela Cilloni

11:15-11:45

Therapeutic Advances in MPN

Dr. Selim Yavuz

11:45-12:15

Transplantation in MPN

Dr. Francesco Frassoni

12.15-12:45

Evidence based management of Essential Thrombocythemia

Dr. Petro E. Petrides

12:45-13:30

Lunch Break

ALL
Moderators:  Dr. Serdar Bedii Omay,  Dr. Mustafa Solak, Dr. Hakan Goker

13:30-14:00

Moleculer Genetics of ALL

Dr. Sabina Chiaretti

14:00-14:30

Ph+ ALL New Era

Dr. Mohamed Said Yousuf Ahmed

14.30-15.00

Transplantation in ALL Acute Lymphoblastic Leukemia in Adolescents Between Pediatric and Adult Camps

Dr. Mohamed Said Yousuf Ahmed

15:00-15:15

Coffee Break

MDS
OModerators: Dr. Peter Greenberg, Dr. Ali Kosar, Dr. Sehmuz Ertop

15:15-15:45

Recent Clinical and Molecular Advances in the Management of MDS Patients

Dr. Peter Greenberg

15:45-16:15

New Drugs in MDS Treatment

Dr. Florian Nolte

16:15-16:45

In Elderly Patients With AML Which Patients Should be Considered Fit or Unfit for Standart Induction Therapy?

Dr. Mehmet Ali Özcan

16:45-17:15

Myelodysplastic Syndromes: Who and When Should Be Transplanted in the Disease Process?

Dr. Francesco Frassoni

CML
Moderators: Dr. Giuseppe Saglio, Dr. Hakan Ozdogu

17:15-17:45

CML Successful Targeted Therapy

Dr. Güray Saydam

17:45-18:15

Is Going For Cure in Chronic Myeloid Leukemia Possible and Justifiable?

Dr. Giuseppe Saglio

11 EKİM 2013 CUMA

CLL and Indolent Lymphomas
Moderators: Dr. Emili Montserrat, Dr. Oktay Faradjev, Dr. Duzgun Ozatli

 09:00-09:30

Implications of New Prognostic Markers in Chronic Lymphocytic Leukemia

Dr. Emili Montserrat

 09:30-10:00

Emerging Role of Kinase-Targeted Strategies in Chronic Lymphocytic Leukemia

Dr. Paolo Ghia 

10:00-10:30

In The Hematological Malignancies, Minimal Residual Disease Criteria During the First Diagnose

Dr. Nikolai Tupitsyn

10:30-11:00

Low Grade Lymphoma Treatment Strategy

Dr. Berksoy Şahin

11:00:11:15

Coffee Break

Yüksek Dereceli Lenfomalar
Oturum Başkanları: Dr. Mehmet Turgut, Dr. Bülent Eser, Dr. İsmail Sarı

11:45-12:15

Therapy of DLCLs

Dr. Alessandro Levis

12:15-12:45

In DLBL’s Treatment When Autogous and When Allogenic Therapy Will Apply?

Dr. Evren Özdemir

12:45-13:30

Lunch Break

STC
Moderators: Dr. Suleyman Dincer, Dr. Saidjalal Bakhramov, Dr. Abdulhalim Rahimjanov

13:30-14:00

Advances in Mobilization Failure

Dr. Nabih Azar

14:00-14:30

Autologous BMT

Dr. Alev Erikçi

14:30-15:00

Bone Marrow Transplantation: Haploidentical Transplantation

Dr. Mustafa Çetin

15:00-15:15

Coffee Break

Multiple Myeloma
Moderators: Dr. Orhan Ayyildiz, Dr. Deniz Sargin, Dr. Filiz Vural

15:15-15:45

How to Use New Biology to Guide Therapy in Multiple Myeloma

Dr. Michel Delforge

15:45-16:15

The Treatment of Posttransplantation in Multiple Myeloma: Minimal Residual Disease Control

Dr. Sergey Şhamanskiy

16:15-16:45

Doublets, Triplets, or Quadruplets of Novel Agents in Newly Diagnosed Myeloma?

Dr. Rafat Abanour

12 October 2013 Saturday

Iron Overload
Moderators: Dr. Maria Domenica Cappellini, Dr. Salih Aksu

09:00-09:30

How I treat my hemoglobinopathy patients?

Dr. Maria Domenica Cappellini

09:30-10:00

Methods to quantify Iron Overload. How reliable is ferritin plasmatic concentration?

Dr. Antonio Piga

10:00-10:30

Stem Cell Transplantation and Gene Therapy in the B-Hemoglobinopathies

Dr. Emanuele Angelucci

10:30-10:45

Coffee Break

AML
Moderators: Dr. Melek Koksal Erkisi Dr. Nilgun Sayinalp, Dr. Mustafa Cetiner

10.45-11:15

Aplastic Anemia: Therapeutic Updates in Immunosuppression and Transplantation

Dr. Emanuele Angelucci

11:15-11:45

APL: A Curable Leukemia Without Chemotherapy

Dr. Erdal Kurtoğlu

11:45-12:15

Minimal Residual Disease in Acute Myeloid Leukemis: Coming of Age

Dr. Mehmet Yılmaz

12:45-13:30

Lunch Break

CML
Moderators: Dr. Suleyman Dincer, Dr. Hakan Ozdogu

13:30-14:00

Monitoring Disease Response in Chronic-Phase Chronic Myloid Leukemia: The Age of Moleculer Assays? What Place for FISH Analysis in CML

Dr. Elias Jabbour

Special Topics
Moderators: Dr. Yurdanur Kilinc, Dr. Turker Cetin, Dr. Atilla Tanyeli

14:00-14:30

PNH, Atypical HUS

Dr. Mustafa Nuri Yenerel

14:30-15:00

ITP , New Treatment Strategy

Dr. Fahri Şahin

15:00 –15:15

Coffee Break

Poster Bildiri Ödülleri ve Sunumları
Oturum Başkanları: Dr. Birol Güvenç, Dr. Güray Saydam

15:15-15:45

Communique Presentations

Special Topics
Moderators: Dr. Ahmet Faik Oner, Dr. Bulent Zulfikar, Dr. Armen Gasparyan

15:45-16:15

Hemophilia, Outcome and Complication

Dr. Alphan Küpesiz

16:15-16:45

Basic Plasma Fractionation

Dr. Zera Tellier

16:45-17:15

Hemophilia Gene Therapy

Dr. Bülent Antmen

17:15-18:15

Rational Use of Drugs

Dr. Kamil Vural